First US experience with Pipeline Flex with Shield Technology using aspirin as antiplatelet monotherapy

Flow diversion has revolutionised the treatment of intracranial aneurysms, and the Pipeline Embolization Device (PED) remains the only flow diverter (FD) approved in the USA. However, thromboembolic events remain an issue for FDs. Attempting to minimise these incidents, a newer PED has been develope...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Case Rep
Glavni autori: Hanel, Ricardo A, Aguilar-Salinas, Pedro, Brasiliense, Leonardo BC, Sauvageau, Eric
Format: Artigo
Jezik:Inglês
Izdano: BMJ Case Reports 2017
Teme:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5612433/
https://ncbi.nlm.nih.gov/pubmed/28473431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-219406
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items